Author

Mesfer Mohammad Al-Shahrani

Associate Professor of Clinical Biochemistry - Cited by 216 - Neurometabolic and mitochondrial disorders

Biography

Mesfer Mohammad Al-Shahrani is a professor in the department of f Clinical Biochemistry, College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia.His research interests reflect in wide range of publications in various national and international journals.International experience includes various programs, contributions and participation in different countries for diverse fields of study.  
Title
Cited by
Year
Oxidative stress: mechanistic insights into inherited mitochondrial disorders and Parkinson’s disease
M Al Shahrani, S Heales, I Hargreaves, M OrfordJournal of Clinical Medicine 6 (11), 100, 2017201
68
2017
Drug-induced mitochondrial toxicity
IP Hargreaves, M Al Shahrani, L Wainwright, SJR HealesDrug safety 39, 661-674, 2016201
59
2016
Synergistic efficacies of thymoquinone and standard antibiotics against multi-drug resistant isolates
AA Dera, I Ahmad, P Rajagopalan, M Al Shahrani, A Saif, MY Alshahrani, ...Saudi Medical Journal 42 (2), 196, 2021202
15
2021
Measurement of antioxidant activity in selected food products and nutraceuticals
MM Al-Shahrani, GS Zaman, M AmanullahJ Nutr Food Sci 3 (3), 2013201
11
2013
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
CE Toomey, WE Heywood, JR Evans, J Lachica, SN Pressey, SC Foti, ...Acta Neuropathologica Communications (1), 1-25, 2022202
10
2022
Assessing the potential impact of COVID-19 Omicron variant: Insight through a fractional piecewise model
XP Li, MH DarAssi, MA Khan, CW Chukwu, MY Alshahrani, M Al Shahrani, ...Results in Physics 3, 105652, 2022202
8
2022
Hemoglobinopathies: An update on the prevalence trends in Southern Saudi Arabia
M Makkawi, S Alasmari, AA Hawan, MM Al Shahrani, AA DeraSaudi Medical Journal 42 (7), 74, 2021202
8
2021
Identification of New Mycobacterium tuberculosis Proteasome Inhibitors Using a Knowledge-Based Computational Screening Approach
TM Almeleebia, MA Shahrani, MY Alshahrani, I Ahmad, AM Alkahtani, ...Molecules 26 (8), 2326, 2021202
7
2021
Increased mRNA expression of key cytokines among suspected cases of Pneumocystis jirovecii infection
MY Alshahrani, M Alfaifi, M Al Shahrani, AS Alshahrani, AG Alkhathami, ...BMC Infectious Diseases 21, 1-10, 2021202
6
2021
Insilco and Invitro approaches identify novel dual PI3K/AKT pathway inhibitors to control acute myeloid leukemia cell proliferations
M Abohassan, M Alshahrani, MY Alshahrani, P RajagopalanMedical Oncology 39 (12), 249, 2022202
5
2022
High-throughput virtual screening and preclinical analysis identifies CB-1, a novel potent dual B-Raf/c-Raf inhibitor, effective against wild and mutant variants of B-Raf …
M Al Shahrani, M Abohassan, M Y. Alshahrani, AR Hakami, ...Journal of Computer-Aided Molecular Design 35, 1165-1176, 2021202
4
2021
Cassia auriculata leaf extract ameliorates diabetic nephropathy by attenuating autophagic necroptosis via RIP‐1/RIP‐3‐p‐p38MAPK signaling
Cassia auriculata leaf extract ameliorates diabetic nephropathy by attenuating autophagic necroptosis via RIP‐1/RIP‐‐p‐p8MAPK signalingM Al Shahrani, HC Chandramoorthy, M Alshahrani, M Abohassan, RA Eid, ...Journal of Food Biochemistry 45 (7), e1810, 2021202
3
2021
Detection of chikungunya virus in the Southern region, Saudi Arabia
AR Hakami, AA Alshamrani, M Alqahtani, Y Alraey, RA Alhefzi, S Alasmari, ...Virology Journal 18 (1), 1-7, 2021202
3
2021
Current strategies for the biochemical diagnosis and monitoring of mitochondrial disease
IP HargreavesMDPI, 2018201
3
2018
FNF-12, a novel benzylidene-chromanone derivative, attenuates inflammatory response in in vitro and in vivo asthma models mediated by M2-related Th2 cytokines via MAPK and NF …
FNF-1, a novel benzylidene-chromanone derivative, attenuates inflammatory response in in vitro and in vivo asthma models mediated by M-related Th cytokines via MAPK and NF …M Abohassan, M Al Shahrani, MY Alshahrani, N Begum, ...Pharmacological Reports 74 (1), 96-110, 0
2
2022
Computational and in vitro characterization of ICY‐5: A potential candidate promoting mitochondrial apoptosis via the c‐MET and STAT3 pathways
M Al Shahrani, M Balasubramaniam, MY Alshahrani, A Saif, AA Dera, ...Journal of Cellular Physiology 236 (), 46-56, 20220
1
2021
Effects of Photobiomodulation Therapy on Glycemic and Lipid Profiles In Vitro
AR Hakami, S Alasmari, M Makkawi, AA Mansour, I Ahmad, ...Medical Lasers; Engineering, Basic Research, and Clinical Application 9 (2 …, 2020202
1
2020
CB-RAF600E-1 exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathways
CB-RAF600E- exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathwaysM Al Shahrani, P Rajagopalan, M Abohassan, M Alshahrani, Y AlraeySaudi Journal of Biological Sciences 29 (6), 03285, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=qbACYRoAAAAJ&hl=en

Cited by
Citations 216
h-index 7
i10-index 5
Open Access Journals